SR NO. GENERIC NAME COMPOSITION STRENGTH
1 Ofloxacin Oral Suspension IP Each 5ml Contains: - Ofloxacin In a flavoured base Approved colour used 50 mg q.s.
2 Ofloxacin Oral Suspension IP Each 5ml Contains: - Ofloxacin In a flavoured base Approved colour used 100 mg q.s.
3 Paracetamol Oral Suspension IP Each 5ml Contains: - Paracetamol In a flavoured base Approved colour used 500 mg q.s.
4 Paracetamol Paediatric Oral Suspension IP Each 5ml Contains: - Paracetamol In a flavoured base Approved colour used 125 mg q.s.
5 Paracetamol Paediatric Oral Suspension IP Each 5ml Contains: - Paracetamol In a flavoured base Approved colour used 250 mg q.s.
6 Paracetamol Paediatric Syrup IP Each 5ml Contains: - Paracetamol In a flavoured syrupy base Approved colour used 125 mg q.s.
7 Azithromycin Oral Suspension IP Each 5ml Contains: - Azithromycin Dihydrate Eq. to Anhydrous Azithromycin In a flavoured Syrupy base Approved colour used 40 mg q.s.
8 Azithromycin Oral Suspension IP Each 5ml Contains: - Azithromycin Dihydrate Eq. to Anhydrous Azithromycin In a flavoured Syrupy base Approved colour used 50 mg q.s.
9 Azithromycin Oral Suspension IP Each 5ml Contains: - Azithromycin Dihydrate Eq. to Anhydrous Azithromycin In a flavoured Syrupy base Approved colour used 200 mg q.s.
10 Albendazole Oral Suspension IP Each 5ml Contains: - Albendazole In a flavoured Syrupy base Approved colour used 200 mg q.s.
11 Cetirizine Hydrochloride Syrup IP Each 5ml Contains: - Cetirizine Hydrochloride In a flavoured Syrupy base Approved colour used 5 mg
12 Sodium Valproate Oral Solution IP Each 5 ml contains: Sodium Valproate Excipients Approved Colour used 200 mg q.s.
13 Paracetamol Suspension IP Each 5 ml contains: Paracetamol Flavoured vehicle base Excipients Approved Colour used 120 mg q.s.
14 Levocetirizine Dihydrochloride Syrup Each 5 ml contains: Levocetirizine Dihydrochloride Excipients In a flavoured syrupy base Approved Colour used 2.5 mg q.s.
15 Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup Each 5 ml contains: Ambroxol Hydrochloride Levosalbutamol Sulphate Eq. to Levosalbutamol Guaiphenesin Excipients In a flavoured syrupy base Approved Colour used 15 mg 0.5 mg 50 mg q.s.
16 Ambroxol Hydrochloride, Levosalbutamol Sulphate & Guaiphenesin Syrup Each 5 ml Contains: Ambroxol Hydrochloride Levosalbutamol Sulphate Eq. to Levosalbutamol Guaiphenesin In flavoured Syrupy base Approved colour used 30 mg 1 mg 50 mg q.s.
17 Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup Each 5 ml Contains: Dextromethorphan Hydrobromide Chlorpheniramine Maleate Phenylephrine Hydrochloride In a pleasantly flavoured Syrupy Approved colour used 10 mg 2 mg 5 mg q.s.
18 Ambroxol, Terbutaline sulphate, Guaiphenesin & menthol syrup Each 5 ml contains: Ambroxol Hcl Terbutaline Sulphate Gauiphenesin Menthol In flavoured Syrupy base Approved colour Used 15 mg 1.25 mg 50 mg 2.5 mg q.s.
19 Zinc Gluconate Suspension Each 5 ml contains: Zinc Gluconate Eq. to elemental Zinc In a flavoured syrupy base Approved Colour used 20 mg q.s.
20 Deflazacort Oral Suspension Each 5 ml of suspension contains: Deflazacort Excipients Approved Colour used 6 mg q.s.
21 Levodropropizine & Chlorpheniramine Maleate Syrup Each 5 ml contains: Levodropropizine Chlorpheniramine Maleate In a flavoured syrupy base Approved Colour used 30 mg 2 mg q.s.
22 Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Each 5 ml contains: Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a flavoured Palatable base. Approved Colour used 15 mg 1.25 mg 50 mg 1 mg q.s.
23 Povidone-Iodine Solution IP Povidone-Iodine (Available Iodine 0.5% w/v) Purified Water 5% w/v q.s.
24 Liquid Paraffin, Milk of Magnesia & Sodium Picosulphate Suspension Each 5 ml contains: Liquid Paraffin Milk of Magnesia Sodium Picosulphate Approved Colour used 1.25 ml 3.75 ml 3.33 mg q.s.
25 Levocetirizine Dihydrochloride and Montelukast Sodium Syrup Each 5 ml contains: Levocetirizine Dihydrochloride Montelukast Sodium Eq. to Montelukast In a flavoured syrupy base Approved Colour used 2.5 mg 4 mg q.s.
26 Cyproheptadine Hydrochloride & Tricholine Citrate in Sorbitol Solution Syrup Each 5 ml contains: Cyproheptadine Hydrochloride (Anhydrous) Tricholine Citrate Sorbitol Solution (70%) base (Non Crystallizing) In a flavoured syrupy base Approved Colour used 2 mg 275 mg 375 mg q.s.
27 Vitamin B-Complex with L-Lysine Syrup Each 5 ml contains: Pyridoxine Hydrochloride Nicotinamide Cyanocobalamin L-Lysine Hydrochloride Sorbitol Solution (70 %) (Non crystallising) Approved Colour used Appropriate overages of vitamins are added to compensate for loss on storage. 0.75 mg 15 mg 2 mcg 37.5 mg q.s.
28 Lactulose Solution IP Each 15 ml contains: Lactulose Concentrate Eq. to Lactulose Aqueous base Approved Colour used 10 gm q.s.
29 Dextromethorphan Hydrobromide, Phenylephirine Hydrochloride and Chlorpheniramine Maleate Syrup "Each 5ml contains: Dextromethorphan Hydrobromide Phenylephirine Hydrochloride " Chlorpheniramine Maleate In flavoured syrupy base Approved Colour used 15 mg 5 mg 2.5 mcg q.s.
30 Cyproheptadine Syrup IP Each 5ml Contains: Cyproheptadine Hydrochloride (anhydrous) In flavoured syrupy base Approved Colour used 2 mg q.s.
31 Paracetamol and Mefenamic Acid Syrup Each 5ml Contains: Paracetamol Mefenamic Acid In flavoured syrupy base Approved Colour used 250 mg 100 mg q.s.
32 Chloramphenicol Palmitate Oral Suspension IP Each 5ml Contains: Chloramphenicol Palmitate Eq. to Chloramphenicol In flavoured syrupy base Approved Colour used 125 mg q.s
33 Promethazine Syrup IP Each 5ml (one teaspoonful) Contains: Promethazine Hydrochloride In flavoured syrupy base Approved Colour used 5 mg q.s.
34 Ondansetron Oral Solution IP Each 5ml contains: Ondansetron Hydrochloride Eq. to Ondansetron In a flavoured syrupy base Approved Colour used 2 mg q.s.
35 Ranitidine Oral Solution IP Each 5ml contains: Ranitidine Hydrochloride Eq. to Ranitidine In a flavoured syrupy base Approved Colour used 75 mg q.s.
36 Ibuprofen and Paracetamol Suspension Each 5ml Contains: Ibuprofen Paracetamol In flavoured syrupy base Approved Colour used 100mg 162.5mg q.s.
37 Sucralfate & Oxetacaine Oral Suspension Each 10ml Contains: Sucralfate Oxetacaine In palatable sorbitol base Approved Colour used 1g 20mg q.s.
Fill the Number